Edition:
United States

Immunovia AB (publ) (IMMNOV.ST)

IMMNOV.ST on Stockholm Stock Exchange

169.20SEK
5:41am EDT
Change (% chg)

-3.60kr (-2.08%)
Prev Close
172.80kr
Open
176.80kr
Day's High
176.80kr
Day's Low
168.00kr
Volume
12,111
Avg. Vol
26,559
52-wk High
199.00kr
52-wk Low
75.50kr

Latest Key Developments (Source: Significant Developments)

Immunovia Q1 Operating Loss Widens To SEK 17.4 Million
Friday, 27 Apr 2018 02:00am EDT 

April 27 (Reuters) - IMMUNOVIA AB (PUBL) ::Q1 NET SALES SEK 112,000 VERSUS SEK 28,000 YEAR AGO.COMPANY HAS A TARGET OF ACHIEVING TURNOVER OF SEK 250-300 MILLION BY 2021.TARGET OF TOTAL TURNOVER OF SEK 800-1,000 BY 2023.Q1 OPERATING LOSS SEK 17.4 MILLION VERSUS LOSS SEK 7.9 MILLION YEAR AGO.  Full Article

Immunovia Aims To Reach SEK 250-300 Million In Turnover In 2021​
Monday, 12 Mar 2018 03:30am EDT 

March 12 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA ANNOUNCES FINANCIAL TARGETS.‍GOAL IS TO REACH SEK 250-300 MILLION IN TURNOVER IN 2021​.‍GOAL IS TO REACH TURNOVER OF SEK 800-1,000 MILLION IN 2023​.‍EXPECTS FIRST REVENUES FROM SELF-PAY SALES DURING Q4 OF 2018​.TARGET OF SEK 250-300 MILLION IN TURNOVER IN 2021,.TO ACHIEVE A TURNOVER OF SEK 250-300 MILLION IN 2021 BASED ON SELF-PAY FOR IMMRAY™ PANCAN-D..  Full Article

Immunovia AB Q4 Net Sales Sek ‍​ 26,000 Versus Sek 106,000 Year Ago
Thursday, 15 Feb 2018 02:00am EST 

Feb 15 (Reuters) - IMMUNOVIA AB ::Q4 NET SALES SEK ‍​ 26,000 VERSUS SEK 106,000 YEAR AGO.Q4 PRETAX LOSS SEK ‍​ 15.3 MILLION VERSUS LOSS SEK 5.4 MILLION YEAR AGO.  Full Article

Immunovia Q3 net loss widens to SEK 11.6 mln‍​
Friday, 10 Nov 2017 02:30am EST 

Nov 10 (Reuters) - IMMUNOVIA AB (PUBL) :NET SALES FOR Q3 2017 WERE SEK 27 THOUSAND (5 K)‍​.THE NET LOSS FOR Q3 2017 WAS SEK 11,589 THOUSAND (-4,048 K)‍​.  Full Article

Immunovia gets SEK 4.9 mln grant from Swelife Accelerator Innovation Program
Monday, 30 Oct 2017 11:41am EDT 

Oct 30 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA RECEIVES SEK4.9 MILLION GRANT FROM SWELIFE ACCELERATOR INNOVATION PROGRAM.  Full Article

Immunovia starts cooperation with ‍Linköping University Medical Faculty ​
Monday, 23 Oct 2017 04:35am EDT 

Oct 23 (Reuters) - IMMUNOVIA AB (PUBL) :STARTS COOPERATION WITH ‍LINKÖPING UNIVERSITY MEDICAL FACULTY ​.  Full Article

Immunovia announces cooperation with Lund University on diabetes research ‍​
Thursday, 7 Sep 2017 09:52am EDT 

Sept 7 (Reuters) - IMMUNOVIA AB (PUBL) ::ANNOUNCES COOPERATION WITH LUND UNIVERSITY ON DIABETES RESEARCH ‍​.  Full Article

Immunovia Q2 operating loss widens to SEK 10.6‍​ million
Wednesday, 23 Aug 2017 02:30am EDT 

Aug 23 (Reuters) - IMMUNOVIA AB (PUBL) :Q2 NET SALES SEK 68,000‍​ VERSUS SEK 66,000 YEAR AGO.Q2 OPERATING LOSS SEK 10.6‍​ MILLION VERSUS LOSS SEK 3.0 MILLION YEAR AGO.  Full Article

Immunovia establishes US headquarters in Boston, Massachusetts
Wednesday, 28 Jun 2017 02:30am EDT 

June 28 (Reuters) - IMMUNOVIA AB (PUBL) :IMMUNOVIA ESTABLISHES US HEADQUARTERS, INCLUDING CLIA REFERENCE LABORATORY, IN BOSTON.‍BOSTON, MASSACHUSETTS USA, HAS BEEN CHOSEN AS LOCATION FOR HEADQUARTERS OF IMMUNOVIA INC, A WHOLLY OWNED SUBSIDIARY.  Full Article

Immunovia biomarker signature for diagnosis of pancreatic cancer patented in Japan
Tuesday, 13 Jun 2017 09:09am EDT 

June 13 (Reuters) - IMMUNOVIA AB (PUBL) ::IMMUNOVIA'S BIOMARKER SIGNATURE FOR DIAGNOSIS OF PANCREATIC CANCER NOW PATENTED IN JAPAN.  Full Article